SAN DIEGO—Top researchers gathered for a review course at the start of the 2017 ACR/ARHP Annual Meeting in November to describe new research, their own treatment strategies and new ways of thinking about an array of rheumatic diseases. Here are the highlights: Raynaud’s & Other Digit Problems When a patient walks into your clinic with…
Search results for: ankylosis
ICD-10 2.0: An Evolving Data Set
One year after the official go-live of the International Classification of Diseases, 10th revision (ICD-10), the coding language is scheduled to undergo an evolution, with nearly 1,975 additions, more than 300 deletions and 425 revisions. This brings the total set of diagnosis codes to more than 71,480. The new and revised clinical modification codes (ICD-10-CM)…
How Magnetic Resonance Imaging Technology Can Aid Spondyloarthritis Diagnosis
SAN FRANCISCO—“We haven’t made a lot of progress in ensuring the early diagnosis of spondyloarthritis,” said Walter Maksymowych, MD, FRCP, professor of medicine in the Division of Rheumatology at the University of Alberta and chief medical officer at CaRE (Canadian Research and Education) Arthritis, both in Edmonton. Speaking at the California Rheumatology Alliance 2016 Medical…
Imaging in Ankylosing Spondylitis
MRI inflammation, fat and new bone formation in the sacroiliac joints, spine in patients with AS
The Diagnostic View: Our Findings
Radiograph, MR images reveal symmetric erosive sacroiliitis in a patient who was diagnosed with ankylosing spondylitis
What’s New in Inflammatory Arthritis?
Rheumatology experts at the ACR’s State-of-the-Art Clinical Symposium in Chicago discuss latest drug therapies, insights into axial spondyloarthritis and bone erosion, repair
Rheumatologists Make Progress Defining Spectrum of Axial Spondyloarthritis
New research clarifies terminology used for diagnosis, but questions remain around epidemiology, genetics and management of patients with axial skeletal inflammation
Treating Early-Stage Spondyloarthritis May Prevent Disease Progression, Say Researchers at the ACR/ARHP Winter Rheumatology Symposium
Therapy with tumor necrosis factor inhibitors, nonsteroidal antiinflammatory drugs, ustekinumab in early stages of osteitis may halt molecular switching to bone-forming phenotype characteristic of SpA
New Insights into CPPD
Progress in research, outcomes, diagnosis, and treatment of calcium pyrophosphate dihydrate crystal deposition disease
A&R Abstracts: Methotrexate
For further reading